secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pelthos Therapeutics Inc. (PTHS)
CIK:        0001919246
Form:       8-K
Filed at:   2025-09-03T23:59:59+00:00
Accession:  0001753926-25-001425
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pelthos Therapeutics to present at Wells Fargo 2025 Healthcare Conference on Sept 3
--------------------------------------------------------------------------------

- CEO Scott Plesha and CFO Frank Knuettel to present at Wells Fargo Healthcare Conference on Sept 3, 2025 at 1:30 pm ET.
- Company to provide pipeline update and discuss commercial launch of ZELSUVMI (berdazimer) for molluscum contagiosum.
- Webcast and replay available on company's website for 90 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1919246/000175392625001425/0001753926-25-001425-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1919246/000175392625001425/g084940_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-25-001425

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer